BETTER LIFE THROUGH BETTER MEDICINE
Live / Applied — Second extension granted (statement of use) (as of 18 Dec 2025)
What this means for you
Not registered yet, but its 25 Mar 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98466116
- Mark type
- Stylized text
- Filed
- 25 Mar 2024
- Published for opposition
- 26 Nov 2024
- Attorney of record
- Michael S. Hargis
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cancer, heart failure, heart disease, and hypertension; pharmaceutical preparations for use in gene therapy; pharmaceutical preparations for the treatment of cancer, heart failure, heart disease, and hypertension, in the form of oncology injectables and oral solids
Owner
- Areva Pharmaceuticals Inc., Georgetown, IN, US
- Areva Pharmaceuticals Inc., Georgetown, IN, US
Prosecution history
- 19 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Dec 2025 — SOU EXTENSION 2 GRANTED
- 18 Dec 2025 — SOU EXTENSION 2 FILED
- 18 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 17 Jun 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Jun 2025 — SOU EXTENSION 1 GRANTED
- 16 Jun 2025 — SOU EXTENSION 1 FILED
- 16 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 05 May 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 05 May 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 05 May 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 05 May 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 07 Jan 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 26 Nov 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 Nov 2024 — PUBLISHED FOR OPPOSITION